Niraparib in Patients With Newly Diagnosed Advanced Ovarian Cancer

Antonio González-Martín, Bhavana Pothuri, Ignace Vergote, René De Pont Christensen, Whitney Graybill, Mansoor R. Mirza, Colleen Mccormick, Domenica Lorusso, Paul Hoskins, Gilles Freyer, Klaus Baumann, Kris Jardon, Andrés Redondo, Richard G. Moore, Christof Vulsteke, Roisin E. O'cearbhaill, Bente Lund, Floor Backes, Pilar Barretina-Ginesta, Ashley F. HaggertyMaria J. Rubio-Pérez, Mark S. Shahin, Giorgia Mangili, William H. Bradley, Ilan Bruchim, Kaiming Sun, Izabela A. Malinowska, Yong Li, Divya Gupta, Bradley J. Monk

Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

OriginalsprogEngelsk
TidsskriftObstetrical and Gynecological Survey
Vol/bind75
Udgave nummer1
Sider (fra-til)29-31
ISSN0029-7828
DOI
StatusUdgivet - 1. jan. 2020

Citationsformater

González-Martín, A., Pothuri, B., Vergote, I., Christensen, R. D. P., Graybill, W., Mirza, M. R., Mccormick, C., Lorusso, D., Hoskins, P., Freyer, G., Baumann, K., Jardon, K., Redondo, A., Moore, R. G., Vulsteke, C., O'cearbhaill, R. E., Lund, B., Backes, F., Barretina-Ginesta, P., ... Monk, B. J. (2020). Niraparib in Patients With Newly Diagnosed Advanced Ovarian Cancer. Obstetrical and Gynecological Survey, 75(1), 29-31. https://doi.org/10.1097/OGX.0000000000000756